(-0.11%) 5 141.25 points
(-0.10%) 38 520 points
(-0.03%) 17 900 points
(-0.25%) $82.42
(1.72%) $2.07
(-0.89%) $2 336.80
(-1.93%) $27.13
(-0.46%) $957.10
(0.20%) $0.934
(0.37%) $11.02
(0.17%) $0.797
(-0.09%) $93.21
Live Chart Being Loaded With Signals
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally...
Stats | |
---|---|
本日の出来高 | 13.10M |
平均出来高 | 31.55M |
時価総額 | 31.14B |
EPS | CNY0 ( 2024-04-25 ) |
Last Dividend | CNY0 ( N/A ) |
Next Dividend | CNY0 ( N/A ) |
P/E | 21.98 |
ATR14 | CNY0.0230 (0.12%) |
ボリューム 相関
Pharmaron Beijing Co., 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Pharmaron Beijing Co., 相関 - 通貨/商品
Pharmaron Beijing Co., 財務諸表
Annual | 2023 |
収益: | CNY11.46B |
総利益: | CNY3.80B (33.18 %) |
EPS: | CNY0.900 |
FY | 2023 |
収益: | CNY11.46B |
総利益: | CNY3.80B (33.18 %) |
EPS: | CNY0.900 |
FY | 2022 |
収益: | CNY10.27B |
総利益: | CNY3.77B (36.71 %) |
EPS: | CNY0.780 |
FY | 2021 |
収益: | CNY7.44B |
総利益: | CNY2.68B (35.99 %) |
EPS: | CNY2.05 |
Financial Reports:
No articles found.
Pharmaron Beijing Co.,
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through five segments: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Services; Clinical Development Services; Biologics and Cell and Gene Therapy Services; and Others. It offers laboratory chemistry solutions, including medicinal, synthetic, and analytical and purification chemistry, as well as computer-aided drug design services; bioscience services comprising in vitro and in vivo drug metabolism and pharmacokinetics/absorption, distribution, metabolism, and excretion solutions; and in vitro biology and in vivo pharmacology, safety assessment, and the U.S. laboratory services. The company also provides process development and manufacturing, material science/pre-formulation, formulation development and manufacturing, and analytical development services; and radiolabelled science services and early stage clinical trial services, as well as clinical research and site management services. It also provides business development; and contract research, development, and manufacturing services for pharmaceutical products. The company was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。